Follow the people · Insider

KC

Kevin James Craig

Insider · Chief Medical Officer · ATAI

Kevin James Craig files insider transactions with the SEC as a chief medical officer of AtaiBeckley. We hold 3 disclosed purchases and sales filed since 6 March 2025, 1 of them in the last 90 days.

  • Files forATAI
  • Disclosed buys and sells3 in all, 1 in the last 90 days
  • Last disclosure11 September 2026

Positions held

1 post we hold — a term names its own dates; a run of filings only says when they filed
  • Filed 3 March 202511 September 2026Chief Medical Officer · AtaiBeckley 36 Form 4 lines · source: SEC Form 4

Every transaction

36 transactions from SEC Form 4 — one row each, sort any column, open a row for the filing
36 of 36 shown
11 Sep 202611 Sep 2026SEC Form 40 dreturned to the issuernot a tradeAtaiBeckley8,437 sharesup +0.0%up +0.0%
11 Sep 202611 Sep 2026SEC Form 40 dreturned to the issuernot a tradeAtaiBeckleyderivative10,000 sharesup +0.0%up +0.0%
11 Sep 202611 Sep 2026SEC Form 40 dreturned to the issuernot a tradeAtaiBeckleyderivative50,400 sharesup +0.0%up +0.0%
11 Sep 202611 Sep 2026SEC Form 40 dreturned to the issuernot a tradeAtaiBeckleyderivative28,608 sharesup +0.0%up +0.0%
11 Sep 202611 Sep 2026SEC Form 40 dreturned to the issuernot a tradeAtaiBeckleyderivative372,701 sharesup +0.0%up +0.0%
11 Sep 202611 Sep 2026SEC Form 40 dreturned to the issuernot a tradeAtaiBeckleyderivative673,808 sharesup +0.0%up +0.0%
11 Sep 202611 Sep 2026SEC Form 40 dreturned to the issuernot a tradeAtaiBeckleyderivative675,000 sharesup +0.0%up +0.0%
11 Sep 202611 Sep 2026SEC Form 40 dreturned to the issuernot a tradeAtaiBeckleyderivative150,000 sharesup +0.0%up +0.0%
25 Jun 202629 Jun 2026SEC Form 44 dexercised options overnot a tradeAtaiBeckley33,051 sharesup +60.5%up +37.1%
25 Jun 202629 Jun 2026SEC Form 44 dexercised options overnot a tradeAtaiBeckley9,528 sharesup +60.5%up +37.1%
25 Jun 202629 Jun 2026SEC Form 44 dsold on the open marketAtaiBeckley42,579 sharesup +60.5%up +37.1%
25 Jun 202629 Jun 2026SEC Form 44 dexercised options overnot a tradeAtaiBeckleyderivative33,051 sharesup +60.5%up +37.1%
25 Jun 202629 Jun 2026SEC Form 44 dexercised options overnot a tradeAtaiBeckleyderivative9,528 sharesup +60.5%up +37.1%
20 Apr 202622 Apr 2026SEC Form 42 dexercised options overnot a tradeAtaiBeckley27,280 sharesup +50.0%up +56.1%
20 Apr 202622 Apr 2026SEC Form 42 dexercised options overnot a tradeAtaiBeckley15,299 sharesup +50.0%up +56.1%
20 Apr 202622 Apr 2026SEC Form 42 dsold on the open marketAtaiBeckley42,579 sharesup +50.0%up +56.1%
20 Apr 202622 Apr 2026SEC Form 42 dexercised options overnot a tradeAtaiBeckleyderivative27,280 sharesup +50.0%up +56.1%
20 Apr 202622 Apr 2026SEC Form 42 dexercised options overnot a tradeAtaiBeckleyderivative15,299 sharesup +50.0%up +56.1%
20 Mar 202624 Mar 2026SEC Form 44 dexercised options overnot a tradeAtaiBeckley76,224 sharesup +110.6%up +117.5%
20 Mar 202624 Mar 2026SEC Form 44 dexercised options overnot a tradeAtaiBeckley23,776 sharesup +110.6%up +117.5%
20 Mar 202624 Mar 2026SEC Form 44 dsold on the open marketAtaiBeckley100,000 sharesup +110.6%up +117.5%
20 Mar 202624 Mar 2026SEC Form 44 dexercised options overnot a tradeAtaiBeckleyderivative76,224 sharesup +110.6%up +117.5%
20 Mar 202624 Mar 2026SEC Form 44 dexercised options overnot a tradeAtaiBeckleyderivative23,776 sharesup +110.6%up +117.5%
20 Mar 202624 Mar 2026SEC Form 44 dexercised options overnot a tradeAtaiBeckleyderivative76,224 sharesup +110.6%up +117.5%
20 Mar 202624 Mar 2026SEC Form 44 dexercised options overnot a tradeAtaiBeckleyderivative23,776 sharesup +110.6%up +117.5%
20 Mar 202624 Mar 2026SEC Form 44 dexercised options overnot a tradeAtaiBeckley76,224 sharesup +110.6%up +117.5%
20 Mar 202624 Mar 2026SEC Form 44 dexercised options overnot a tradeAtaiBeckley23,776 sharesup +110.6%up +117.5%
20 Mar 202624 Mar 2026SEC Form 44 dsold on the open marketAtaiBeckley100,000 sharesup +110.6%up +117.5%
30 Jan 20263 Feb 2026SEC Form 44 dwas grantednot a tradeAtaiBeckleyderivative675,000 sharesup +95.5%up +89.9%
30 Jan 20263 Feb 2026SEC Form 44 dwas grantednot a tradeAtaiBeckleyderivative150,000 sharesup +95.5%up +89.9%
30 Jan 20263 Feb 2026SEC Form 44 dwas grantednot a tradeAtaiBeckleyderivative675,000 sharesup +95.5%up +89.9%
30 Jan 20263 Feb 2026SEC Form 44 dwas grantednot a tradeAtaiBeckleyderivative150,000 sharesup +95.5%up +89.9%
21 Mar 202524 Mar 2025SEC Form 43 dsold on the open marketATAI Life Sciences11,563 sharesup +406.9%up +368.2%
14 Mar 202519 Mar 2025SEC Form 45 dexercised options overnot a tradeATAI Life Sciencesderivative20,000 sharesup +396.6%up +428.8%
14 Mar 202519 Mar 2025SEC Form 45 dexercised options overnot a tradeATAI Life Sciences20,000 sharesup +396.6%up +428.8%
3 Mar 20256 Mar 2025SEC Form 43 dwas grantednot a tradeATAI Life Sciencesderivative757,915 sharesup +390.0%up +368.2%

Both percentages are the stock’s move, not Kevin James Craig’s return: a disclosure gives a band, never an amount, so nobody can say how much was bought or what it made. They run to the last close we hold11 Sep 2026, except where a name has since delisted, when the row names its own last session. We publish no close, no volume and no dollar figure behind them. 36 of the 36 rows shown carry a percentage; the rest are dashes with the reason on the row.

Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.

Some filings reach us as photographs of paper rather than as a form we can read as text. Those are shown here only once they have been read and checked, so this page can hold fewer lines than the filings behind it contain. The link on every row opens the original document, which is always the full record.